Avadel Gets Competing Bid from Lundbeck
Avadel Pharmaceuticals receives unsolicited $23/share offer from Lundbeck, competing with existing $20/share Alkermes deal. Board reviewing superior proposal.
NOTRELOAD AI
Jefferies Upgrades Gap to Buy as Turnaround Gains Momentum
Jefferies upgrades Gap to Buy with a new $30 price target, citing strong brand turnaround, rising momentum at Athleta, and big potential in the beauty segment.
Applied Materials Stock Drops 6% on China Export Curb Concerns
Applied Materials forecasts reduced China spending in 2026 due to U.S. export restrictions, causing shares to fall 6%. Company expects recovery in second half of 2026.
Warner Bros. Discovery Attracts Bids from Paramount, Comcast, and Netflix
Warner Bros. Discovery faces acquisition interest from Paramount, Comcast, and Netflix as the media giant seeks buyers by year-end. First-round bids due November 20.
Merck's $9.2B Cidara Takeover: Big Pharma's Fight for Flu Innovation
Merck wins bidding war for Cidara Therapeutics at $9.2B, more than double its market value, securing groundbreaking long-acting flu antibody treatment as Big Pharma races for cutting-edge medicines.
Luminar Q3 2025: Revenue Up 20% But Cash Crisis Deepens
Luminar (LAZR) reports 20% revenue increase in Q3 2025 but faces serious cash crunch with only $74M remaining. Company exploring sale options and restructuring debt.